Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease
- PMID: 29564257
- PMCID: PMC5848392
- DOI: 10.4103/jfmpc.jfmpc_158_17
Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease
Abstract
Introduction: Nonalcoholic fatty liver disease (NAFLD) is raising prevalence among children, and adolescence population in developed and developing countries as a major public health concern. The present study aims to determine the relationship between serum ferritin level and transient elastography findings in patients suffering from NAFLD.
Materials and methods: The demographic and biochemical profile of included individuals such as body mass index, age, level of serum transaminases, fasting blood sugar, lipid profile, and serum ferritin level were determined and a transient elastography was performed for all of them.
Results: The mean serum ferritin level among men with mild and advanced liver stiffness was 154 ± 97 and 244 ± 214, respectively (P < 0.001), which showed a meaningful relationship. These figures among female patients with mild and advanced liver stiffness included 79 ± 91 and 161 ± 103, respectively (P = 0.003) and again revealed a significant relationship. The cutoff values of ferritin with 90% accuracy for differentiation of mild from advanced liver stiffness among male and female patients were determined as 255 ng/ml and 135 ng/ml, respectively. These cutoff values for ruling out of advanced liver stiffness with 90% accuracy among both sexes were 72.5 ng/ml and 65.5 ng/ml, respectively.
Conclusion: The finding of this study revealed a significant relationship between serum ferritin level and liver stiffness among NAFLD patients, and if these results repeated in further investigations, it could be advisable to measure serum ferritin level for predicting possibility of advanced liver fibrosis.
Keywords: Ferritin; nonalcoholic fatty liver disease; transient elastography.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.Indian J Gastroenterol. 2015 May;34(3):200-8. doi: 10.1007/s12664-015-0572-5. Epub 2015 Jun 25. Indian J Gastroenterol. 2015. PMID: 26108652
-
Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter.Eur J Gastroenterol Hepatol. 2020 Aug;32(8):1008-1016. doi: 10.1097/MEG.0000000000001608. Eur J Gastroenterol Hepatol. 2020. PMID: 31834057
-
Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography.Ultrasonography. 2021 Jul;40(3):407-416. doi: 10.14366/usg.20147. Epub 2020 Dec 18. Ultrasonography. 2021. PMID: 33561928 Free PMC article.
-
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.J Med Ultrason (2001). 2020 Oct;47(4):511-520. doi: 10.1007/s10396-020-01058-y. Epub 2020 Oct 21. J Med Ultrason (2001). 2020. PMID: 33089412 Review.
-
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13. Clin Ther. 2021. PMID: 34400007 Review.
Cited by
-
Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.Diabetes Metab Syndr Obes. 2023 Jul 31;16:2255-2268. doi: 10.2147/DMSO.S417754. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37545743 Free PMC article.
-
Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review.Front Med (Lausanne). 2022 Aug 3;9:934989. doi: 10.3389/fmed.2022.934989. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35991666 Free PMC article.
-
Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease.Front Physiol. 2022 Dec 14;13:1046497. doi: 10.3389/fphys.2022.1046497. eCollection 2022. Front Physiol. 2022. PMID: 36589424 Free PMC article. Review.
References
-
- Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 2008;134:1682–98. - PubMed
-
- Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–62. - PubMed
-
- Wiener C, Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, et al. Harrisons Principles of Internal Medicine Self-Assessment and Board Review. 18th ed. New York: McGraw Hill Professional; 2012.
-
- Savadkouhi F, HosseiniTabatabaei SMT, Shahabi Nezhad S. The frequency of fatty liver in sonographu of patients without liver disease background and its correlation with blood cholesterol and triglyceride. Zahedan J Res Med Sci. 2003;5:177–83.
-
- Adibi A, Kelishadi R, Beihaghi A, Salehi H, Talaei M. Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan. Endokrynol Pol. 2009;60:14–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources